Intercell Signs Exclusive Agreement for Marketing and Distribution of its Japanese Encephalitis Vaccine in Japan and Korea

January 19, 2009 – Intercell AG announced it has signed an exclusive agreement with Novartis AG for the marketing and distribution of Intercell’s vaccine candidate to prevent Japanese Encephalitis, in Japan and Korea.

The details can be read here.